Veletri and Proair hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Veletri (epoprostenol sodium) and Proair hfa (albuterol sulfate). Common drug interactions include swelling among females and device occlusion among males.

The phase IV clinical study analyzes what interactions people have when they take Veletri and Proair hfa. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Veletri?

Veletri has active ingredients of epoprostenol sodium. eHealthMe is studying from 14,196 Veletri users. Check the latest studies of Veletri.

What is Proair hfa?

Proair hfa has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 53,227 Proair hfa users. Check the latest studies of Proair hfa.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

48 people who take Veletri and Proair hfa together, and have interactions are studied.

Veletri and Proair hfa drug interactions.

What are the common drug interactions of Veletri and Proair Hfa, by gender? *:

female:

  1. Swelling
  2. Urinary tract infection
  3. Arthralgia (joint pain)
  4. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  5. Device dislocation
  6. Cardiac failure congestive
  7. Hypotension (abnormally low blood pressure)
  8. Weight decreased
  9. Bone pain
  10. Fluid retention (an abnormal accumulation of fluid in the blood)

male:

  1. Device occlusion
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Diarrhoea
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Emotional distress
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Hypotension (abnormally low blood pressure)
  8. International normalised ratio increased
  9. Jugular vein thrombosis (clot in jugular vein)
  10. Nervousness

What are the common drug interactions of Veletri and Proair Hfa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal distension
  2. Cough
  3. Nausea (feeling of having an urge to vomit)
  4. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)

20-29:

  1. Abdominal distension
  2. Cough
  3. Nausea (feeling of having an urge to vomit)

30-39:

  1. Fluid retention (an abnormal accumulation of fluid in the blood)
  2. Hospitalisation
  3. Pulmonary hypertension (increase in blood pressure in the lung artery)
  4. Abdominal pain
  5. Abscess (pus)
  6. Acute respiratory failure
  7. Back pain
  8. Chest pain
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Device occlusion

40-49:

  1. Diarrhoea
  2. Pain in jaw
  3. Nausea (feeling of having an urge to vomit)
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Cellulitis (infection under the skin)
  6. Abdominal pain
  7. Flushing (the warm, red condition of human skin)
  8. Pain
  9. Constipation
  10. Fatigue (feeling of tiredness)

50-59:

  1. Abdominal pain
  2. Blood potassium decreased
  3. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Pain in extremity
  6. Abdominal pain lower
  7. Back pain
  8. Cellulitis (infection under the skin)
  9. Clostridium test positive
  10. Cyclic vomiting syndrome (prolonged episodes of severe nausea, vomiting)

60+:

  1. Headache (pain in head)
  2. Nausea (feeling of having an urge to vomit)
  3. Pneumonia
  4. Asthenia (weakness)
  5. Decreased appetite
  6. Diarrhoea
  7. Hypotension (abnormally low blood pressure)
  8. Acute respiratory failure
  9. Adverse event
  10. Anaemia (lack of blood)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 40 people, 83.33%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 10 people, 20.83%
  3. Nausea (feeling of having an urge to vomit): 9 people, 18.75%
  4. Diarrhea: 6 people, 12.50%
  5. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 6.25%
  6. Nausea And Vomiting: 3 people, 6.25%
  7. Dyspnea (difficult or laboured breathing): 3 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Veletri and Proair hfa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Veletri and Proair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Veletri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Proair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Veletri and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proair hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on epoprostenol sodium and albuterol sulfate (the active ingredients of Veletri and Proair hfa, respectively), and Veletri and Proair hfa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: